These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 36678667)
1. Intranasal Delivery of Liposomes to Glioblastoma by Photostimulation of the Lymphatic System. Semyachkina-Glushkovskaya O; Shirokov A; Blokhina I; Telnova V; Vodovozova E; Alekseeva A; Boldyrev I; Fedosov I; Dubrovsky A; Khorovodov A; Terskov A; Evsukova A; Elovenko D; Adushkina V; Tzoy M; Agranovich I; Kurths J; Rafailov E Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678667 [TBL] [Abstract][Full Text] [Related]
2. Photomodulation of Lymphatic Delivery of Bevacizumab to the Brain: The Role of Singlet Oxygen. Semyachkina-Glushkovskaya O; Diduk S; Anna E; Elina D; Artem K; Khorovodov A; Shirokov A; Fedosov I; Dubrovsky A; Blokhina I; Terskov A; Karandin G; Evsukova A; Tsven A; Telnova V; Afranovich I; Sokolovski S; Rafailov E; Kurths J Adv Exp Med Biol; 2022; 1395():53-57. PubMed ID: 36527613 [TBL] [Abstract][Full Text] [Related]
3. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials. Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126 [TBL] [Abstract][Full Text] [Related]
4. Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies. Goel H; Kalra V; Verma SK; Dubey SK; Tiwary AK J Control Release; 2022 Jan; 341():782-811. PubMed ID: 34906605 [TBL] [Abstract][Full Text] [Related]
5. A Novel Delivery System of Cyclovirobuxine D for Brain Targeting: Angiopep-Conjugated Polysorbate 80-Coated Liposomes via Intranasal Administration. Wei H; Liu T; Jiang N; Zhou K; Yang K; Ning W; Yu Y J Biomed Nanotechnol; 2018 Jul; 14(7):1252-1262. PubMed ID: 29944099 [TBL] [Abstract][Full Text] [Related]
6. Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease. Singh S; Shukla R AAPS PharmSciTech; 2023 Sep; 24(7):179. PubMed ID: 37658972 [TBL] [Abstract][Full Text] [Related]
8. Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives. Hong SS; Oh KT; Choi HG; Lim SJ Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31627301 [TBL] [Abstract][Full Text] [Related]
9. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797 [TBL] [Abstract][Full Text] [Related]
10. Development of Lomustine and Katona G; Sabir F; Sipos B; Naveed M; Schelz Z; Zupkó I; Csóka I Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336006 [TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery. Duong VA; Nguyen TT; Maeng HJ Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678838 [TBL] [Abstract][Full Text] [Related]
12. Low-Level Laser Treatment Induces the Blood-Brain Barrier Opening and the Brain Drainage System Activation: Delivery of Liposomes into Mouse Glioblastoma. Semyachkina-Glushkovskaya O; Bragin D; Bragina O; Socolovski S; Shirokov A; Fedosov I; Ageev V; Blokhina I; Dubrovsky A; Telnova V; Terskov A; Khorovodov A; Elovenko D; Evsukova A; Zhoy M; Agranovich I; Vodovozova E; Alekseeva A; Kurths J; Rafailov E Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839889 [TBL] [Abstract][Full Text] [Related]
13. Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders. Islam SU; Shehzad A; Ahmed MB; Lee YS Molecules; 2020 Apr; 25(8):. PubMed ID: 32326318 [TBL] [Abstract][Full Text] [Related]
14. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics. Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670 [TBL] [Abstract][Full Text] [Related]
15. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases. Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945 [TBL] [Abstract][Full Text] [Related]
16. Exploring intranasal drug delivery via nanocarriers: A promising glioblastoma therapy. Deshmukh V; Pathan NS; Haldar N; Nalawade S; Narwade M; Gajbhiye KR; Gajbhiye V Colloids Surf B Biointerfaces; 2024 Sep; 245():114285. PubMed ID: 39366109 [TBL] [Abstract][Full Text] [Related]
17. Current strategic arsenal and advances in nose to brain nanotheranostics for therapeutic intervention of glioblastoma multiforme. Kumar A; Shukla R J Biomater Sci Polym Ed; 2024 Sep; ():1-35. PubMed ID: 39250527 [TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of drug delivery to the brain via nasal route. Kozlovskaya L; Abou-Kaoud M; Stepensky D J Control Release; 2014 Sep; 189():133-40. PubMed ID: 24997277 [TBL] [Abstract][Full Text] [Related]
19. Drug delivery systems from nose to brain. Misra A; Kher G Curr Pharm Biotechnol; 2012 Sep; 13(12):2355-79. PubMed ID: 23016642 [TBL] [Abstract][Full Text] [Related]
20. Design and Application in Delivery System of Intranasal Antidepressants. Xu J; Tao J; Wang J Front Bioeng Biotechnol; 2020; 8():626882. PubMed ID: 33409272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]